Treatment of hyperthyroidism with potassium iodide.

Abstract

Potassium iodide was given to 17 cases of Basedow's disease in comparison to 12 normal controls for 5 weeks. In the thyrotoxic patients, the maximum decrease in serum T3 and T4 levels was observed 2 and 3 weeks, respectively, but in some cases remained normal even at 5 weeks. The euthyroid persons showed a small decrease in T4 and T3 and an increase in serum TSH.

• Authors: G Philippou, G Piperingos, A Souvatzoglou, D A Koutras, S D Moulopoulos
• Journal: Experimental and clinical endocrinology (Exp Clin Endocrinol) Vol. 97 Issue 2-3 Pg. 308-11 (May 1991) ISSN: 0232-7384 [Print] Germany
• PMID: 1915648 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Triiodothyronine
• Potassium Iodide
• Thyrotropin
• Thyroxine

Topics

• Adult
• Female
• Graves Disease (drug therapy)
• Humans
• Hyperthyroidism (drug therapy)
• Male
• Potassium Iodide (therapeutic use)
• Thyrotropin (blood)
• Thyroxine (blood)
• Triiodothyronine (blood)